Press Releases

DUBLIN--(BUSINESS WIRE)-- The "World - Carbon Dioxide - Market Analysis, Forecast, Size, Trends and Insights" report has been added to ResearchAndMarkets.com's offering. The report provides an in-depth analysis of supply and demand for carbon dioxide on the global market. It will help you

DUBLIN--(BUSINESS WIRE)-- The "Guillain-Barre Syndrome - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Guillain-Barre Syndrome (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route

DUBLIN--(BUSINESS WIRE)-- The "Behcet Disease - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Behcet Disease - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Behcet Disease (Cardiovasc

TORONTO & CATHEDRAL CITY, Calif.--(BUSINESS WIRE)-- Halo Labs Inc. ("Halo" or the "Company") (NEO:HALO) is pleased to announce it has entered into an agreement with Falcon International Corp. (“Falcon”) to supply a minimum of 50,000 and up to 70,000 grams per week of bulk cannabis distillate used for vaping at US$7.50 per gram totaling between approximately US$1.6 million and US$2.2 milli

STRASBOURG, France--(BUSINESS WIRE)-- Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, today announced that the first patient of a Phase 1/2 clinical trial evaluating TG6002 in patients with advanced gastrointestinal tumors, such as colon cancers, has been dosed at Centre L&eac

DUBLIN--(BUSINESS WIRE)-- The "Binge Eating Disorder - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Binge Eating Disorder - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Binge Eating

DUBLIN--(BUSINESS WIRE)-- The "Rett Syndrome - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Rett Syndrome - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Rett Syndrome (Central Nervo

JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Healogics Inc., the nation’s largest provider of advanced wound care services, today announced their support of the American Diabetes Association (ADA) Compendium

DUBLIN--(BUSINESS WIRE)-- The "Industrial Metals, Precious Metals

DUBLIN--(BUSINESS WIRE)-- The "Global Robotic Process Automation Market by Process, by Industry - Forecast & Opportunities, 2013-2023" report has been added to ResearchAndMarkets.com's offering. The global RPA market is expected to cross USD7,000 Million by 2024, with a CAGR over 27

WASHINGTON--(BUSINESS WIRE)-- The Department of Navy, Naval Undersea Warfare Center, Newport, RI, has awarded Alion Science and Technology, headquartered in McLean, Va., a multiple award contract (MAC) Indefinite Delivery/Indefinite Quantity (ID/IQ), to develop, build, and support the U.S. Navy Unmanned Undersea Vehicle (UUV) Family of Systems (FoS). The scope of the contract covers systems and subsystems requi

DUBLIN--(BUSINESS WIRE)-- The "Global Aerial Imagery Market by Application, by Vertical, by Type - Size and Forecast 2014-2024" report has been added to ResearchAndMarkets.com's offering. The global aerial imagery market is expected to cross USD 4,000 million by 2024, with a CAGR over 12

SOUTHPORT, Conn.--(BUSINESS WIRE)-- Sturm, Ruger & Company, Inc. (NYSE: RGR) will announce its financial results for the third quarter and file its Quarterly Report on Form 10-Q on Wednesday, October 31, 2018, after the close of the stock market. On Thursday, November 1, 2018, Sturm, Ruger will host a webcast at 9:00 a.m. ET to discuss the third quarter operating results. Interested parties can a

ALACHUA, Fla.--(BUSINESS WIRE)-- Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that industry veteran Timothy Cooke, Ph.D., has joined the Company as Senior Vice President of Commercial Business. “Tim brings to Ology Bioservices more than 25 years of experience in the development of vaccines and immunotherapeutics at a number of

NEW YORK & DECATUR, Ill.--(BUSINESS WIRE)-- Edgemont Capital Partners, L.P. has acted as exclusive financial advisor to Decatur Radiology Ph